4.6 Article

Diagnosis and management of Barrett esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Guideline

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

Clinical Relevance of Random Biopsies From the Esophagogastric Junction After Complete Eradication of Barrett's Esophagus is Low

Charlotte N. Frederiks et al.

Summary: This study aimed to assess the incidence and long-term outcomes of findings from random esophagogastric junction (EGJ) biopsies after complete eradication of Barrett's esophagus (BE). The study found that persistent intestinal metaplasia (IM) at the EGJ was not associated with a higher risk for recurrent non-dysplastic or dysplastic BE. Recurrent EGJ-IM was also not associated with recurrent non-dysplastic or dysplastic BE.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

The effect of procedural time on dysplasia detection rate during endoscopic surveillance of Barrett's esophagus

Mathew Vithayathil et al.

Summary: For patients with Barrett's esophagus without clearly visible dysplastic lesions, longer procedural time is associated with a higher dysplasia detection rate. Adequate time is needed to perform high-quality surveillance and maximize dysplasia detection.

ENDOSCOPY (2023)

Article Gastroenterology & Hepatology

Hybrid APC in Combination With Resection for the Endoscopic Treatment of Neoplastic Barrett's Esophagus: A Prospective, Multicenter Study

Mate Knabe et al.

Summary: This study evaluated a potential alternative treatment for neoplastic Barrett's esophagus, called hybrid argon plasma ablation. The results showed that this technique achieved the expected eradication and recurrence rates of Barrett's intestinal metaplasia and neoplasia within 2 years. However, a randomized comparative trial is needed to provide final evidence compared to radiofrequency ablation.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2022)

Article Gastroenterology & Hepatology

Image-Enhanced Endoscopy and Molecular Biomarkers Vs Seattle Protocol to Diagnose Dysplasia in Barrett's Esophagus

Mathew Vithayathil et al.

Summary: The study compared the diagnostic accuracy of AFI-guided pCLE with molecular biomarkers and HRWLE with Seattle protocol biopsies for inconspicuous dysplasia in Barrett's esophagus. The results showed similar sensitivity between the two methods, but the addition of molecular biomarkers could improve the detection sensitivity for different grades of dysplasia.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Limitations of Heartburn and Other Societies' Criteria in Barrett's Screening for Detecting De Novo Esophageal Adenocarcinoma

Tarek Sawas et al.

Summary: Existing Barrett's esophagus screening guidelines have limitations in detecting prevalent esophageal adenocarcinoma. An optimized approach is needed to identify individuals most suitable for esophageal adenocarcinoma screening, particularly one that does not rely on chronic reflux symptoms.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Impact of expert center endoscopic assessment of confirmed low grade dysplasia in Barrett's esophagus diagnosed in community hospitals

Esther A. Nieuwenhuis et al.

Summary: One quarter of patients with confirmed low grade dysplasia (LGD) in Barrett's esophagus (BE) diagnosed in a community hospital had high grade dysplasia (HGD) or cancer after re-staging at an expert center. Referral of patients with confirmed LGD, even without visible lesions, for re-staging endoscopy at an expert center is necessary.

ENDOSCOPY (2022)

Article Gastroenterology & Hepatology

Abnormal TP53 Predicts Risk of Progression in Patients With Barrett's Esophagus Regardless of a Diagnosis of Dysplasia

Mark Redston et al.

Summary: This study developed a reliable criteria for grading abnormal p53 immunohistochemical expression and tested its utility as a biomarker for progression in Barrett's esophagus (BE). The findings showed that abnormal p53 expression was strongly associated with neoplastic progression in BE, regardless of histologic diagnosis and could predict progression among nondysplastic BE, indefinite for dysplasia, and low-grade dysplasia.

GASTROENTEROLOGY (2022)

Article Gastroenterology & Hepatology

Endoscopic eradication therapy for Barrett's esophagus-related neoplasia: a final 10-year report from the UK National HALO Radiofrequency Ablation Registry

Paul Wolfson et al.

Summary: Radiofrequency ablation (RFA) treatment is effective and durable in preventing esophageal adenocarcinoma. Most relapses occur early but can be successfully retreated.

GASTROINTESTINAL ENDOSCOPY (2022)

Article Oncology

Use of a Cytosponge biomarker panel to prioritise endoscopic Barrett's oesophagus surveillance: a cross-sectional study followed by a real-world prospective pilot

Nastazja Dagny Pilonis et al.

Summary: By combining Cytosponge, laboratory biomarkers, and clinical factors, endoscopy can be prioritized for patients with Barrett's oesophagus. Three risk groups were identified based on new biomarker analysis: high risk, moderate risk, and low risk. In real-world settings, Cytosponge results accurately identified high-risk patients needing endoscopy.

LANCET ONCOLOGY (2022)

Article Gastroenterology & Hepatology

Individual risk calculator to predict lymph node metastases in patients with submucosal (T1b) esophageal adenocarcinoma: a multicenter cohort study

Annieke W. Gotink et al.

Summary: This study focused on predicting the risk of lymph node metastasis in patients with pT1b EAC after endoscopic resection or surgery. Factors like submucosal invasion depth, tumor size, and lymphovascular invasion were found to be associated with an increased risk of metastases. The developed prediction model demonstrated good discriminative ability in estimating the probability of post-resection metastases.

ENDOSCOPY (2022)

Article Surgery

Predictors of recurrence of dysplasia or cancer in patients with dysplastic Barrett's esophagus following complete eradication of dysplasia: a single-center retrospective cohort study

Ryosuke Kobayashi et al.

Summary: This study found that achieving complete eradication of intestinal metaplasia (CE-IM) following the complete eradication of neoplasia (CE-N) can reduce the risk of recurrent dysplasia.

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2022)

Article Gastroenterology & Hepatology

Long-term outcomes after endoscopic treatment for Barrett's neoplasia with radiofrequency ablation ± endoscopic resection: results from the national Dutch database in a 10-year period

Sanne van Munster et al.

Summary: The study investigated the short-term and long-term outcomes of radiofrequency ablation (RFA) +/- endoscopic resection (ER) for early neoplasia in Barrett's esophagus patients in the Netherlands. The results showed that in a centralized care setting, this treatment approach is effective with low recurrence rates, supporting the use of more lenient follow-up intervals and emphasizing careful endoscopic inspection.
Article Gastroenterology & Hepatology

Prediction of Progression in Barrett's Esophagus Using a Tissue Systems Pathology Test: A Pooled Analysis of International Multicenter Studies

Prasad G. Iyer et al.

Summary: This study evaluates the adjunct value of a tissue systems pathology test in predicting the progression risk in Barrett's esophagus (BE). The results show that the high-risk class of TissueCypher can independently predict the risk of progression to high-grade dysplasia/adenocarcinoma in BE patients and improve the predictive ability compared to using clinical variables alone.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2022

Pedro Pimentel-Nunes et al.

Summary: This guideline provides recommendations for the evaluation and treatment of superficial gastrointestinal lesions. It suggests that experienced endoscopists should use high definition white-light and chromoendoscopy for evaluation and recommends endoscopic submucosal dissection for most lesions. Different treatment approaches are suggested for specific situations. The guideline also provides recommendations for post-resection surveillance and treatment.

ENDOSCOPY (2022)

Article Gastroenterology & Hepatology

Analysis of metastases rates during follow-up after endoscopic resection of early high-risk esophageal adenocarcinoma

Esther A. Nieuwenhuis et al.

Summary: This study evaluated the outcomes of endoscopic follow-up after ER for high-risk esophageal adenocarcinoma. It found that the annual metastasis rate for high-risk submucosal EAC was somewhat lower than expected, but the rate for high-risk intramucosal EAC was concerning.

GASTROINTESTINAL ENDOSCOPY (2022)

Article Cell Biology

The utility of P53 immunohistochemistry in the diagnosis of Barrett's oesophagus with indefinite for dysplasia

Wladyslaw Januszewicz et al.

Summary: This study assessed the utility of p53 immunohistochemistry in evaluating BE-IND specimens. The results showed that p53-IHC reduced the rate of BE-IND diagnoses and improved the interobserver agreement among pathologists.

HISTOPATHOLOGY (2022)

Article Pathology

International Tumor Budding Consensus Conference criteria determine the prognosis of oesophageal adenocarcinoma with poor response to neoadjuvant treatment

Philipp Lohneis et al.

Summary: This study investigated the role of tumor budding as an additional prognostic factor in esophageal adenocarcinomas with poor response to neoadjuvant therapy, finding a strong positive correlation between high numbers of tumor buds and poor prognosis.

PATHOLOGY RESEARCH AND PRACTICE (2022)

Article Gastroenterology & Hepatology

Reducing the environmental footprint of gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastroenterology and Endoscopy Nurses and Associates (ESGENA) Position Statement

Enrique Rodriguez de Santiago et al.

Summary: This position statement raises awareness about the environmental impact of GI endoscopy and provides guidance to reduce it. It recommends immediate action to reduce the impact, adherence to guidelines, implementation of reduce, reuse, and recycle programs, and reassessment of the use of single-use devices. It also suggests including sustainability in training and conducting research to quantify and minimize the impact.

ENDOSCOPY (2022)

Article Gastroenterology & Hepatology

Expected value of artificial intelligence in gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement

Helmut Messmann et al.

Summary: The ESGE defines the expected value of AI for the diagnosis and management of gastrointestinal neoplasia and sets recommendations for its acceptance in different aspects of endoscopy.

ENDOSCOPY (2022)

Article Gastroenterology & Hepatology

Argon plasma coagulation for Barrett's esophagus with low-grade dysplasia: a randomized trial with long-term follow-up on the impact of power setting and proton pump inhibitor dose

Ewa Wronska et al.

Summary: This study evaluated the impact of power setting and proton pump inhibitor dose on the efficacy and safety of argon plasma coagulation for treating Barrett's esophagus with low-grade dysplasia. The results showed that power setting and PPI dose did not significantly affect the ablation of Barrett's esophagus, with over 90% of patients maintaining complete ablation in the long term without evidence of neoplasia progression.

ENDOSCOPY (2021)

Article Gastroenterology & Hepatology

Prevalence of Barrett's esophagus and performance of societal screening guidelines in an unreferred primary care population of US veterans

Theresa H. Nguyen et al.

Summary: This study examined the prevalence of Barrett's esophagus in a previously unscreened primary care population and evaluated the performance of various BE screening guidelines. The findings suggest that guidelines requiring GERD symptoms have low sensitivity, while those not requiring GERD have low specificity. The study proposes a screening guideline with better utilization of known risk factors.

GASTROINTESTINAL ENDOSCOPY (2021)

Review Gastroenterology & Hepatology

Global prevalence of Barrett's oesophagus and oesophageal cancer in individuals with gastro-oesophageal reflux: a systematic review and meta-analysis

Leonardo Henry Eusebi et al.

Summary: Chronic gastro-oesophageal reflux can lead to the development of Barrett's oesophagus or oesophageal adenocarcinoma. Global prevalence of Barrett's oesophagus varies geographically and is significantly higher in men. Low-grade dysplasia is common in histologically confirmed cases of Barrett's oesophagus.
Article Gastroenterology & Hepatology

Neutrophil to lymphocyte ratio and risk of neoplastic progression in patients with Barrett's esophagus

Noam Peleg et al.

Summary: NLR can serve as a predictor for histologic progression in patients with BE, with a high discriminatory capacity for progression to HGD and EAC, especially effective in patients with NDBE.

ENDOSCOPY (2021)

Article Pathology

Tumor budding assessed according to the criteria of the International Tumor Budding Consensus Conference determines prognosis in resected esophageal adenocarcinoma

Philipp Lohneis et al.

Summary: Tumor budding in esophageal adenocarcinomas, evaluated according to the ITBCC criteria, is an independent prognostic factor associated with reduced overall survival. Regardless of the quantification approach used, an increased number of tumor buds is significantly correlated with worse overall survival. Prospective studies using ITBCC criteria are needed to confirm these findings in the future.

VIRCHOWS ARCHIV (2021)

Review Oncology

Tumour budding in solid cancers

Alessandro Lugli et al.

Summary: Tumour budding serves as an emerging prognostic biomarker in colorectal cancer and other solid cancers, with its predictive accuracy being widely supported by evidence. The standardized scoring system agreed upon at the International Tumour Budding Consensus Conference allows for an independent prediction of pathological features and unfavorable survival outcomes in patients.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Article Gastroenterology & Hepatology

Endoscopic resection versus esophagectomy for patients with small-sized T1N0 esophageal cancer: A propensity-matched study

Wenjia Wang et al.

Summary: This study compared the outcomes of ER and esophagectomy for small-sized T1a and T1b esophageal cancer patients, finding that in stage T1 esophageal cancer, ER was similar to esophagectomy in terms of oncologic outcomes, and more prospective studies should be implemented for T1b patients.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

Massively Parallel Sequencing of Esophageal Brushings Enables an Aneuploidy-Based Classification of Patients With Barrett's Esophagus

Christopher Douville et al.

Summary: RealSeqS analysis of esophageal brushings provides a practical and sensitive method to determine aneuploidy in patients with Barrett's esophagus. It identifies specific chromosome changes that occur early in the disease and others that occur late and mark disease progression. The clinical implications of this approach can now be tested in prospective trials.

GASTROENTEROLOGY (2021)

Article Pathology

Clinicopathologic correlations of superficial esophageal adenocarcinoma in endoscopic submucosal dissection specimens

Sadhna Dhingra et al.

Summary: This study retrospectively evaluated 49 consecutive ESD resection specimens from 42 patients with BE-associated adenocarcinoma and found that histopathologic features associated with poor outcomes included poor differentiation, lymphovascular invasion, and submucosal invasion > 500 µm. Positive deep margin distant from deepest tumor invasion could be procedural and warrants endoscopic correlation for management.

DIAGNOSTIC PATHOLOGY (2021)

Article Gastroenterology & Hepatology

Prevalence of Barrett's esophagus in a Southern European country: a multicenter study

Ines Marques de Sa et al.

Summary: The study aimed to determine the prevalence of Barrett's esophagus in a Southern European country, with results showing a low overall prevalence in an unselected population, and higher prevalence in men compared to women. Future studies are needed to determine progression rates of BE and ways to improve quality metrics.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Barrett's esophagus with low-grade dysplasia: high rate of upstaging at Barrett's esophagus referral units suggests progression rates may be overestimated

Edward H. Tsoi et al.

Summary: This study aimed to determine the proportion of prevalent HGD or EAC detected in Barrett's esophagus (BE) patients referred from the community with a recent diagnosis of low-grade dysplasia (LGD). The results showed that BERU assessment endoscopy identified more visible lesions than community referral endoscopy and identified HGD or EAC in 27% of patients referred from the community with a recent diagnosis of LGD. Reported progression rates from LGD to HGD or EAC may be overestimated.

GASTROINTESTINAL ENDOSCOPY (2021)

Article Gastroenterology & Hepatology

Endoscopic radiofrequency ablation or surveillance in patients with Barrett's oesophagus with confirmed low-grade dysplasia: a multicentre randomised trial

Maximilien Barret et al.

Summary: This study found through a randomized trial that radiofrequency ablation therapy can moderately reduce the prevalence of low-grade dysplasia (LGD) in Barrett's esophagus over 3 years and decrease the risk of progression. The complication rate was highest after the first radiofrequency ablation treatment.
Article Oncology

Do proton pump inhibitors prevent Barrett's esophagus progression to high-grade dysplasia and esophageal adenocarcinoma? An updated meta-analysis

Yue Chen et al.

Summary: The use of PPI is negatively associated with the risk of progression to HGD/EAC in BE patients, and the risk of HGD/EAC can be reduced with the prolonged use of PPI. Sensitivity analysis showed the stable results of this meta-analysis, and no publication bias was detected.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)

Article Gastroenterology & Hepatology

The Optimal Age to Stop Endoscopic Surveillance of Patients With Barrett's Esophagus Based on Sex and Comorbidity: A Comparative Cost-Effectiveness Analysis

Amir-Houshang Omidvari et al.

Summary: This study highlights the importance of considering comorbidity status and sex when determining the optimal age to discontinue surveillance in patients with NDBE. Men are generally recommended a later age for the last surveillance, while women are recommended to discontinue surveillance at a younger age.

GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

Validation of a methylated DNA marker panel for the nonendoscopic detection of Barrett's esophagus in a multisite case-control study

Prasad G. Iyer et al.

Summary: The study recalibrated the performance of a 5 methylated DNA marker panel for nonendoscopic Barrett's esophagus detection using a simplified assay, achieving high accuracy in both training and test sets. Model accuracy was not affected by age, sex, or smoking history. Multiple 3 MDM panels also achieved similar accuracy.

GASTROINTESTINAL ENDOSCOPY (2021)

Article Biochemistry & Molecular Biology

Triage-driven diagnosis of Barrett's esophagus for early detection of esophageal adenocarcinoma using deep learning

Marcel Gehrung et al.

Summary: Deep learning methods have been successfully integrated with expert knowledge and clinical decision pathways to automate the analysis of Cytosponge-TFF3 test samples for the early detection of Barrett's esophagus. By defining triage classes based on pathologists' decision patterns, the workload of pathologists can be reduced by 57% without compromising diagnostic performance. The clinician-in-the-loop deep learning system streamlines the workflow for Barrett's esophagus detection while maintaining the accuracy of manual review.

NATURE MEDICINE (2021)

Review Oncology

Risk of esophageal adenocarcinoma in patients with Barrett's esophagus using proton pump inhibitors: a systematic review with meta-analysis and sequential trial analysis

Lunan Li et al.

Summary: The effect of PPIs on reducing the incidence of EAC and HGD in BE patients has not been confirmed, although some studies suggest a potential protective effect. Additional research with more patients is required to reach a definitive conclusion.

TRANSLATIONAL CANCER RESEARCH (2021)

Article Gastroenterology & Hepatology

Comparative Cost Effectiveness of Reflux-Based and Reflux-Independent Strategies for Barrett's Esophagus Screening

Sarmed S. Sami et al.

Summary: In GERD-independent scenarios, most non-sEGD BE screening tests were cost-effective, with swallowable esophageal cell collection devices with biomarkers being the optimal choice. However, exhaled volatile organic compounds had the highest ICERs in all scenarios.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

Clinical significance of recurrent gastroesophageal junction intestinal metaplasia after endoscopic eradication of Barrett's esophagus

Quinn S. Solfisburg et al.

Summary: Recurrence of intestinal metaplasia at the gastroesophageal junction (GEJIM) after endoscopic eradication of Barrett's esophagus (BE) is common, but not associated with an increased risk of subsequent dysplasia. Older age and longer initial BE length are independently associated with recurrence.

GASTROINTESTINAL ENDOSCOPY (2021)

Review Surgery

Improving cost-effectiveness of endoscopic surveillance for Barrett's esophagus by reducing low-value care: a review of economic evaluations

Ravi Vissapragada et al.

Summary: Studies revealed that guideline-specified endoscopic surveillance for patients with non-dysplastic Barrett's esophagus (NDBE) was not cost-effective. Instead, a strategy of deselecting low-risk NDBE patients from surveillance may be a cost-effective approach.

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2021)

Article Gastroenterology & Hepatology

Barrett's esophagus surveillance in a prospective Dutch multi-center community-based cohort of 985 patients demonstrates low risk of neoplastic progression

Esther Klaver et al.

Summary: This study utilized a large, prospective community-based Barrett's cohort and found that Barrett's length, low-grade dysplasia, and age were important risk factors for progression to HGD/EAC.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2021)

Article Medicine, General & Internal

Economic evaluation of Cytosponge®-trefoil factor 3 for Barrett esophagus: A cost-utility analysis of randomised controlled trial data

Nicholas Swart et al.

Summary: The study found that a one-off Cytosponge-TFF3 screening is cost-effective compared to usual care, especially for patients with gastro-esophageal reflux disease.

ECLINICALMEDICINE (2021)

Article Gastroenterology & Hepatology

Standalone performance of artificial intelligence for upper GI neoplasia: a meta-analysis

Julia Arribas et al.

Summary: Studies have evaluated the diagnostic performance of artificial intelligence in detecting and characterizing upper gastrointestinal lesions, showing a high overall accuracy for diagnosing any neoplastic lesion of the upper GI tract independently of the underlying condition.
Article Gastroenterology & Hepatology

Endoscopic Resection Without Subsequent Ablation Therapy for Early Barrett's Neoplasia: Endoscopic Findings and Long-Term Mortality

S. N. van Munster et al.

Summary: After endoscopic resection, it is recommended to ablate the remaining Barrett's esophagus to reduce the risk of further disease. However, a study in the Netherlands found that in selected patients, endoscopic surveillance following ER without further ablation therapy can be a valid alternative, with no progression to advanced cancer observed during follow-up.

JOURNAL OF GASTROINTESTINAL SURGERY (2021)

Article Gastroenterology & Hepatology

Recurrence Is Rare Following Complete Eradication of Intestinal Metaplasia in Patients With Barrett's Esophagus and Peaks at 18 Months

Sachin Wani et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

The management and long-term outcomes of endoscopic and surgical treatment of early esophageal adenocarcinoma

John H. Saunders et al.

DISEASES OF THE ESOPHAGUS (2020)

Article Gastroenterology & Hepatology

European Society of Gastrointestinal Endoscopy (ESGE) Publications Policy - Update 2020

Cesare Hassan et al.

ENDOSCOPY (2020)

Article Gastroenterology & Hepatology

Deep learning algorithm detection of Barrett's neoplasia with high accuracy during live endoscopic procedures: a pilot study

Albert J. de Groof et al.

GASTROINTESTINAL ENDOSCOPY (2020)

Article Surgery

Infiltration Depth is the Most Relevant Risk Factor for Overall Metastases in Early Esophageal Adenocarcinoma

Christina Oetzmann von Sochaczewski et al.

WORLD JOURNAL OF SURGERY (2020)

Article Gastroenterology & Hepatology

Radiofrequency ablation for low-grade dysplasia in Barrett's esophagus: long-term outcome of a randomized trial

Roos E. Pouw et al.

GASTROINTESTINAL ENDOSCOPY (2020)

Article Gastroenterology & Hepatology

Accurate Nonendoscopic Detection of Barrett's Esophagus by Methylated DNA Markers: A Multisite Case Control Study

Prasad G. Iyer et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)

Review Gastroenterology & Hepatology

Accuracy of artificial intelligence-assisted detection of upper GI lesions: a systematic review and meta-analysis

Thomas K. L. Lui et al.

GASTROINTESTINAL ENDOSCOPY (2020)

Review Gastroenterology & Hepatology

The global prevalence of Barrett's esophagus: A systematic review of the published literature

Ines Marques de Sa et al.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2020)

Article Gastroenterology & Hepatology

Multifocal Cryoballoon Ablation for Eradication of Barrett's Esophagus-Related Neoplasia: A Prospective Multicenter Clinical Trial

Marcia Irene Canto et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)

Article Biochemistry & Molecular Biology

Genomic copy number predicts esophageal cancer years before transformation

Sarah Killcoyne et al.

NATURE MEDICINE (2020)

Article Gastroenterology & Hepatology

Lower Annual Rate of Progression of Short-Segment vs Long-Segment Barrett's Esophagus to Esophageal Adenocarcinoma

Nour Hamade et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)

Review Gastroenterology & Hepatology

Systematic review and meta-analysis of prevalence and risk factors for Barrett's esophagus

Bashar J. Qumseya et al.

GASTROINTESTINAL ENDOSCOPY (2019)

Article Health Care Sciences & Services

A Cost-Effectiveness Analysis Of An Adenocarcinoma Risk Prediction Multi-Biomarker Assay For Patients With Barrett's Esophagus

Jing Hao et al.

CLINICOECONOMICS AND OUTCOMES RESEARCH (2019)

Article Gastroenterology & Hepatology

Combined EsophaCap cytology and MUC2 immunohistochemistry for screening of intestinal metaplasia, dysplasia and carcinoma

Zhongren Zhou et al.

CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY (2019)

Article Gastroenterology & Hepatology

Highly Discriminant Methylated DNA Markers for the Non-endoscopic Detection of Barrett's Esophagus

Prasad G. Iyer et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)

Review Gastroenterology & Hepatology

Factors Associated With Progression of Barrett's Esophagus: A Systematic Review and Meta-analysis

Rajesh Krishnamoorthi et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)

Article Gastroenterology & Hepatology

Cryotherapy and Radiofrequency Ablation for Eradication of Barrett's Esophagus with Dysplasia or Intramucosal Cancer

Prashanthi N. Thota et al.

DIGESTIVE DISEASES AND SCIENCES (2018)

Review Gastroenterology & Hepatology

Validation of a biomarker panel in Barrett's esophagus to predict progression to esophageal adenocarcinoma

S. Eluri et al.

DISEASES OF THE ESOPHAGUS (2018)

Review Gastroenterology & Hepatology

The Effect of Endoscopic Surveillance in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis

Don Chamil Codipilly et al.

GASTROENTEROLOGY (2018)

Article Gastroenterology & Hepatology

Development of Evidence-Based Surveillance Intervals After Radiofrequency Ablation of Barrett's Esophagus

Cary C. Cotton et al.

GASTROENTEROLOGY (2018)

Article Gastroenterology & Hepatology

Squamous Cellular Carcinoma Antigen Serum Determination as a Biomarker of Barrett Esophagus and Esophageal Cancer A Phase III Study

Gemma Maddalo et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2018)

Article Cell Biology

Identifying DNA methylation biomarkers for non-endoscopic detection of Barrett's esophagus

Helen R. Moinova et al.

SCIENCE TRANSLATIONAL MEDICINE (2018)

Article Gastroenterology & Hepatology

Adherence to quality indicators in endoscopic surveillance of Barrett's esophagus and correlation to dysplasia detection rates

Andrew Antony et al.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2018)

Article Gastroenterology & Hepatology

Endoscopic management and follow-up of patients with a submucosal esophageal adenocarcinoma

H. T. Kunzli et al.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2018)

Review Gastroenterology & Hepatology

Validation of a biomarker panel in Barrett's esophagus to predict progression to esophageal adenocarcinoma

S. Eluri et al.

DISEASES OF THE ESOPHAGUS (2018)

Article Medicine, General & Internal

Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial

Janusz A. Z. Jankowski et al.

LANCET (2018)

Article Gastroenterology & Hepatology

Adherence to quality indicators and surveillance guidelines in the management of Barrett's esophagus: a retrospective analysis

Donevan Westerveld et al.

ENDOSCOPY INTERNATIONAL OPEN (2018)

Article Gastroenterology & Hepatology

Clinical Outcomes Following Recurrence of Intestinal Metaplasia After Successful Treatment of Barrett's Esophagus With Radiofrequency Ablation

Athidi Guthikonda et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)

Review Gastroenterology & Hepatology

Proton-pump inhibitors: understanding the complications and risks

Peter Malfertheiner et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)

Article Gastroenterology & Hepatology

Recurrence of Barrett's Esophagus is Rare Following Endoscopic Eradication Therapy Coupled With Effective Reflux Control

Srinadh Komanduri et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)

Article Gastroenterology & Hepatology

Can the Risk of Lymph Node Metastases Be Gauged in Endoscopically Resected Submucosal Esophageal Adenocarcinomas? A Multi-Center Study

Joshua A. Boys et al.

JOURNAL OF GASTROINTESTINAL SURGERY (2016)

Article Gastroenterology & Hepatology

The Presence of Genetic Mutations at Key Loci Predicts Progression to Esophageal Adenocarcinoma in Barrett's Esophagus

Swathi Eluri et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)

Article Gastroenterology & Hepatology

The Effect of Proton Pump Inhibitors on Barrett's Esophagus

Kerry B. Dunbar et al.

GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2015)

Article Gastroenterology & Hepatology

Durability and Predictors of Successful Radiofrequency Ablation for Barrett's Esophagus

Sarina Pasricha et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)

Article Gastroenterology & Hepatology

Complete Endoscopic Mucosal Resection Is Effective and Durable Treatment for Barrett's- Associated Neoplasia

Vani J. A. Konda et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)

Article Gastroenterology & Hepatology

Cost-effectiveness of endoscopic surveillance of non-dysplastic Barrett's esophagus

Louisa G. Gordon et al.

GASTROINTESTINAL ENDOSCOPY (2014)

Article Gastroenterology & Hepatology

Endotherapy versus surgery for early neoplasia in Barrett's esophagus: a meta-analysis

Jun Wu et al.

GASTROINTESTINAL ENDOSCOPY (2014)

Article Medicine, General & Internal

Radiofrequency Ablation vs Endoscopic Surveillance for Patients With Barrett Esophagus and Low-Grade Dysplasia A Randomized Clinical Trial

K. Nadine Phoa et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)

Article Genetics & Heredity

Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis

Jamie M. J. Weaver et al.

NATURE GENETICS (2014)

Review Gastroenterology & Hepatology

Efficacy and Durability of Radiofrequency Ablation for Barrett's Esophagus: Systematic Review and Meta-analysis

Eric S. Orman et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)

Review Gastroenterology & Hepatology

Radiofrequency ablation for long- and ultralong-segment Barrett's esophagus: a comparative long-term follow-up study

Parambir S. Dulai et al.

GASTROINTESTINAL ENDOSCOPY (2013)

Article Gastroenterology & Hepatology

European Society of Gastrointestinal Endoscopy (ESGE) Guideline Development Policy

J. -M. Dumonceau et al.

ENDOSCOPY (2012)

Article Surgery

Effects of Nissen fundoplication on endoscopic endoluminal radiofrequency ablation of Barrett's esophagus

Kathleen O'Connell et al.

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2011)

Article Gastroenterology & Hepatology

Low-Grade Dysplasia in Barrett's Esophagus: Overdiagnosed and Underestimated

Wouter L. Curvers et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)

Article Gastroenterology & Hepatology

Safety and efficacy of endoscopic spray cryotherapy for Barrett's esophagus with high-grade dysplasia

Nicholas J. Shaheen et al.

GASTROINTESTINAL ENDOSCOPY (2010)

Article Medicine, General & Internal

Radiofrequency Ablation in Barrett's Esophagus with Dysplasia

Nicholas J. Shaheen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Letter Gastroenterology & Hepatology

Systematic Four-Quadrant Biopsy Detects Barrett's Dysplasia in More Patients Than Nonsystematic Biopsy: Reply

Jo-Etienne Abela et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)

Article Gastroenterology & Hepatology

Early Barrett's Carcinoma With Low-Risk Submucosal Invasion: Long-Term Results of Endoscopic Resection With a Curative Intent

Hendrik Manner et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)

Article Gastroenterology & Hepatology

Systematic four-quadrant biopsy detects Barrett's dysplasia in more patients than nonsystematic biopsy

[Anonymous]

AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)

Article Oncology

Leukocyte telomere length predicts cancer risk in Barrett's esophagus

Rosa Ana Risques et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)

Article Gastroenterology & Hepatology

Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia

Bergein F. Overholt et al.

GASTROINTESTINAL ENDOSCOPY (2007)

Article Gastroenterology & Hepatology

Prevalence of Barrett's esophagus in the general population:: An endoscopic study

J Ronkainen et al.

GASTROENTEROLOGY (2005)

Article Gastroenterology & Hepatology

The cost-effectiveness of biomarkers for predicting the development of oesophageal adenocarcinoma

JH Rubenstein et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)

Article Gastroenterology & Hepatology

Long-term follow-up after complete ablation of Barrett's esophagus with argon plasma coagulation

Ahmed Madisch et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2005)

Article Gastroenterology & Hepatology

The frequency of Barrett's esophagus in high-risk patients with chronic GERD

B Westhoff et al.

GASTROINTESTINAL ENDOSCOPY (2005)